RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Charles River Laboratories International - Stock

Charles River Laboratories International EBIT 2024

Charles River Laboratories International EBIT

868.84 M USD

Charles River Laboratories International Dividend yield

Ticker

CRL

ISIN

US1598641074

WKN

939391

In 2024, Charles River Laboratories International's EBIT was 868.84 M USD, a 31.78% increase from the 659.32 M USD EBIT recorded in the previous year.

The Charles River Laboratories International EBIT history

YEAREBIT (undefined USD)
2029e-
2028e1.28
2027e1.19
2026e1.07
2025e0.97
2024e0.87
20230.66
20220.66
20210.63
20200.45
20190.38
20180.36
20170.29
20160.26
20150.23
20140.19
20130.15
20120.17
20110.19
20100.13
20090.18
20080.25
20070.23
20060.19
20050.18
20040.16

Charles River Laboratories International Aktienanalyse

What does Charles River Laboratories International do?

Charles River Laboratories International Inc. is a global company in the field of life sciences. It offers a wide range of products and services to support drug development and patient care. The company started as a supplier of laboratory animals in 1947 and expanded into the field of toxicology in the 1960s. It is now a leading provider of preclinical studies and tests. Charles River operates in North America, Europe, and Asia, with over 80 facilities and more than 17,000 employees. Its main business model is supporting drug manufacturers and biotechnology companies in the development, testing, and approval of new medications. The company also offers products for research projects, including animal models, cell cultures, and antibodies. Charles River has five main business areas: Early Discovery, Safety Assessment, Biologics Testing Solutions, Biomedical Research Models, and Genetically Engineered Models. Each of these areas focuses on a specific task or market. In addition to these main areas, Charles River also provides tailored services, such as consulting, training, and support, to meet the specific needs of its customers. The company is dedicated to improving the health and well-being of humans and animals and continually strives to enhance the quality of its products and services. Charles River Laboratories International ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Charles River Laboratories International's EBIT

Charles River Laboratories International's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Charles River Laboratories International's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Charles River Laboratories International's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Charles River Laboratories International’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Charles River Laboratories International Stock

How much did Charles River Laboratories International achieve in EBIT for the current year?

In the current year, Charles River Laboratories International has achieved an EBIT of 868.84 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Charles River Laboratories International.

How has the EBIT of Charles River Laboratories International developed in recent years?

The EBIT of Charles River Laboratories International has increased by 31.778% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Charles River Laboratories International?

The EBIT of Charles River Laboratories International is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Charles River Laboratories International pay?

Over the past 12 months, Charles River Laboratories International paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Charles River Laboratories International is expected to pay a dividend of 0 USD.

What is the dividend yield of Charles River Laboratories International?

The current dividend yield of Charles River Laboratories International is .

When does Charles River Laboratories International pay dividends?

Charles River Laboratories International pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Charles River Laboratories International?

Charles River Laboratories International paid dividends every year for the past 0 years.

What is the dividend of Charles River Laboratories International?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Charles River Laboratories International located?

Charles River Laboratories International is assigned to the 'Health' sector.

Wann musste ich die Aktien von Charles River Laboratories International kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Charles River Laboratories International from 6/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/9/2024.

When did Charles River Laboratories International pay the last dividend?

The last dividend was paid out on 6/9/2024.

What was the dividend of Charles River Laboratories International in the year 2023?

In the year 2023, Charles River Laboratories International distributed 0 USD as dividends.

In which currency does Charles River Laboratories International pay out the dividend?

The dividends of Charles River Laboratories International are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Charles River Laboratories International stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Charles River Laboratories International

Our stock analysis for Charles River Laboratories International Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Charles River Laboratories International Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.